DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV INFECTION IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: RESULTS OF A EUROPEAN MULTICENTRE COMPASSIONATE USE PROGRAM

被引:4
作者
Petersen, J. [1 ]
Welzel, T. [2 ]
Herzer, K. [3 ]
Ferenci, P. [4 ]
Gschwantler, M. [5 ]
Cornberg, M. [6 ]
Ingiliz, P. [7 ]
Berg, T. [8 ]
Spengler, U. [9 ]
Weiland, O. [10 ]
van der Valk, M. [11 ]
Klinker, H. [12 ]
Rockstroh, J. [9 ]
Peck-Radosavljevic, M. [13 ]
Zhao, Y. [14 ]
Jimenez-Exposito, M. J. [14 ]
Zeuzem, S. [2 ]
机构
[1] IFI Inst Interdisziplinare Med, Hamburg, Germany
[2] Goethe Univ Frankfurt, Univ Klinikum, Frankfurt, Germany
[3] Univ Klinikum Essen AoR, Essen, Germany
[4] Med Univ Wien, Vienna, Austria
[5] Wilhelminenspital Stadt Wien, Vienna, Austria
[6] Hannover Med Sch, Hannover, Germany
[7] Ctr Infectiol, Berlin, Germany
[8] Univ Klinikum Leipzig, Leipzig, Germany
[9] Univ Klinikum Bonn, Bonn, Germany
[10] Karolinska Univ Hosp Huddinge, Karolinska Inst, Stockholm, Sweden
[11] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
[12] Univ Klinikum Wurzburg, Wurzburg, Germany
[13] Klinikum Klagenfurt, Klagenfurt, Austria
[14] Bristol Myers Squibb, Princeton, NJ USA
关键词
D O I
10.1016/S0168-8278(16)01524-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-184
引用
收藏
页码:S781 / S782
页数:2
相关论文
empty
未找到相关数据